What is Biohaven's restricted cash?

Biohaven (BHVN) reported restricted cash of $2.3M in Q1 2026.

How has Biohaven's restricted cash changed year-over-year?

Biohaven's restricted cash decreased by 27.3% year-over-year, from $3.17M to $2.3M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Biohaven BHVN Restricted Cash

Restricted Cash at other companies

Rapport Therapeutics, Inc.RAPP

$105K0.0%

Vir Biotechnology, Inc.VIR

$8.9M-90.6%

Protagonist TherapeuticsPTGX

$288K+28.0%

Monte Rosa Therapeutics, Inc.GLUE

$4.95M+1.4%

Roivant SciencesROIV

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's restricted cash?: Biohaven (BHVN) reported restricted cash of $2.3M in Q1 2026.
How has Biohaven's restricted cash changed year-over-year?: Biohaven's restricted cash decreased by 27.3% year-over-year, from $3.17M to $2.3M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.